SH3PXD2B
protein-codingSH3 and PX domains 2B
Gene summary
This gene encodes an adapter protein that is characterized by a PX domain and four Src homology 3 domains. The encoded protein is required for podosome formation and is involved in cell adhesion and migration of numerous cell types. Mutations in this gene are the cause of Frank-ter Haar syndrome (FTHS), and also Borrone Dermato-Cardio-Skeletal (BDCS) syndrome. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
- KIAA1295
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~129.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009579
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009579
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009579
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009579
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009579
Submitter: ClinGen
The SH3PXD2B gene is located on chromosome 5 at 5q35.1 and encodes SH3 and PX domains-containing protein 2B, which is an adapter protein involved in invadopodia and podosome formation and extracellular matrix degradation. SH3PXD2B was first reported in relation to autosomal recessive Frank-ter Haar syndrome (FTHS) in 2010 (Iqbal et al., 2010, PMID: 20137777). FTHS is a syndromic disorder characterized by brachycephaly, wide fontanels, prominent forehead, hypertelorism, prominent eyes, macrocornea with or without glaucoma, full cheeks, small chin, bowing of the long bones, and flexion deformity of the fingers. At least two nonsense, three frameshift, one missense, one exonic deletion, and one splice site variants that have been reported in seven probands in three publications (PMID: 20137777; Wilson et al., 2014, PMID: 24105366, Zrhidri et al., 2017, PMID: 28694206) and are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be loss of function. This gene-disease relationship is also supported by experimental evidence including a mouse model, functional alteration in patient cells, and rescue in cell culture experiments (PMID: 20137777; Buschman et al., 2009, PMID: 19144821). In summary, there is definitive evidence to support the relationship between SH3PXD2B and autosomal recessive Frank-ter Haar syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on 02.01.2023 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0009579
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Cardiovascular; Ophthalmologic; Pharmacogenomic
Rationale: The condition may be clinically recognizable, but can include macrocornea with or without glaucoma, and surveillance and prompt treatment may be beneficial; Awareness of cardiac anomalies may allow prompt management; Agents that may contribute to glaucoma should be avoided
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SH3PXD2B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001017995.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 126 | 4 | 132 | ||
| missense | 2 | 237 | 28 | 6 | 273 | |
| nonsense | 1 | 2 | 2 | 5 | ||
| start loss | 0 | |||||
| frameshift | 5 | 2 | 8 | 1 | 16 | |
| splice donor/acceptor (+/-2bp) | 2 | 4 | 3 | 9 | ||
| Total | 8 | 10 | 252 | 155 | 10 | 435 |
Highest pathogenic variant AF is 0.000010544048
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001017995.1 | 13 | MANE Select | |
| Ensembl | ENSP00000309714.5 | 13 | MANE Select | |
| RefSeq | NP_001295104.1 | 13 | Standard | |
| Ensembl | ENSP00000428076.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- skeletal system development
- eye development
- osteoblast fate commitment
- superoxide metabolic process
- heart development
Molecular Function
- protein binding
- phosphatidylinositol-5-phosphate binding
- superoxide-generating NADPH oxidase activator activity
- phosphatidylinositol-3-phosphate binding
- phosphatidylinositol binding
Cellular Component
- podosome
- cytoplasm
- cell junction
- cell projection
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000311601
- Coding exons
- 13
- Length
- 129343
- Individuals with no LoFs
- 125568
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 180
- Defined
- 125748
- p
- 0.000716
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.526 | 511 | 546 | 0.937 | 0.0000347 | 5925 |
| Missense (PolyPhen) | 159 | 204.39 | 0.77791 | 2252 | ||
| Synonymous | 0.830 | 213 | 229 | 0.930 | 0.0000162 | 1817 |
| Loss of Function | 4.08 | 12 | 39.8 | 0.301 | 0.00000198 | 465 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000066 | 0.000062 | rare |
| Latino/Admixed American | 0.00064 | 0.00064 | rare |
| Ashkenazi Jewish | 0.0057 | 0.0057 | notable |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00018 | 0.00018 | rare |
| European (Non-Finnish) | 0.00055 | 0.00055 | rare |
| South Asian | 0.00056 | 0.00056 | rare |
| Other | 0.0021 | 0.0021 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Adapter protein involved in invadopodia and podosome formation and extracellular matrix degradation. Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. Plays a role in mitotic clonal expansion during the immediate early stage of adipocyte differentiation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12615925, ECO:0000269|PubMed:19755710, ECO:0000269|PubMed:20609497}.;
- Disease
- DISEASE: Frank-Ter Haar syndrome (FTHS) [MIM:249420]: A syndrome characterized by brachycephaly, wide fontanels, prominent forehead, hypertelorism, prominent eyes, macrocornea with or without glaucoma, full cheeks, small chin, bowing of the long bones and flexion deformity of the fingers. {ECO:0000269|PubMed:20137777}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- LoFtool
- 0.628
- RVIS EVS
- -0.28
- RVIS percentile EVS
- 33.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.128
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |